Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Giulia Maddalena"'
Autor:
Fotios Loupakis, Giulia Maddalena, Ilaria Depetris, Sabina Murgioni, Francesca Bergamo, Angelo Paolo Dei Tos, Massimo Rugge, Giada Munari, Andrew Nguyen, Christopher Szeto, Vittorina Zagonel, Sara Lonardi, Matteo Fassan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-7 (2019)
Abstract Background Analysis of deficiency in DNA mismatch repair (dMMR) is currently considered a standard molecular test in all patients with colorectal cancer (CRC) for its implications in screening, prognosis and prediction of benefit from immune
Externí odkaz:
https://doaj.org/article/42bd19ba238948ee815a95ee2bf81be2
Autor:
Alessandra A. Prete, Paolo Manca, Marco Messina, Vincenzo Formica, Giovanni L. Frassineti, Maria G. Zampino, Domenico C. Corsi, Corrado Orciuolo, Michele Prisciandaro, Francesca Bergamo, Valentina Angerilli, Mario Scartozzi, Mariaelena Casagrande, Gianluca Masi, Monica Ronzoni, Federica Morano, Valentina Vettore, Roberta Salmaso, Cosimo Rasola, Giulia Maddalena, Paola del Bianco, Massimo Milione, Chiara Cremolini, Matteo Fassan, Filippo Pietrantonio, Sara Lonardi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::646fb6217e4d53cfc616a9a1b07819ce
https://hdl.handle.net/11577/3473285
https://hdl.handle.net/11577/3473285
Autor:
Giovanni Centonze, Marco Volante, Angelo Paolo Dei Tos, Alessandra Boccaccino, Giuseppe Aprile, Massimo Milione, Lorenzo Calvetti, Lorenza Rimassa, Giovanna De Maglio, Emanuela Dell'Aquila, Daniele Santini, Giulia Maddalena, Chiara Cremolini, Sara Lonardi, Vittorina Zagonel, Lisa Salvatore, Massimo Di Maio, Paola Biason, Fotios Loupakis, Chiara Borga, Matteo Fassan, Valeria Smiroldo, Marta Schirripa, Federica Morano, Clizia Zichi, Nicoletta Pella, Roberta Salmaso, Filippo Pietrantonio, Elisa Sperti, F. Cortiula, Francesca Bergamo
Publikováno v:
European Journal of Cancer. 146:145-154
Background Neuroendocrine differentiation has been extensively associated with worse prognosis and to mechanisms of therapy resistance in several epithelial cancers. A high prevalence of neuroendocrine differentiation was recently described in V600EB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::281836252cf5fd3099ad131bc322ed0a
https://doi.org/10.1016/j.ejca.2021.01.016
https://doi.org/10.1016/j.ejca.2021.01.016
Autor:
Giovanni, Randon, Giulia, Maddalena, Marco Maria, Germani, Chiara Carlotta, Pircher, Paolo, Manca, Francesca, Bergamo, Mirella, Giordano, Caterina, Sposetti, Aldo, Montagna, Guglielmo, Vetere, Luca, Zambelli, Cosimo, Rasola, Alessandra, Boccaccino, Filippo, Pagani, Margherita, Ambrosini, Marco, Massafra, Gabriella, Fontanini, Massimo, Milione, Matteo, Fassan, Chiara, Cremolini, Sara, Lonardi, Filippo, Pietrantonio
Publikováno v:
JCO precision oncology. 6
Several uncommon genomic alterations beyondA prospective data set at three Italian Academic Hospitals included 650 patients with mCRC with comprehensive genomic profiling by FoundationOne CDx and treated with anti-EGFRs. PRESSING2 panel alterations w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::88180dcb936f4f9a6946def97c14c538
https://pubmed.ncbi.nlm.nih.gov/35849487
https://pubmed.ncbi.nlm.nih.gov/35849487
Autor:
Letizia Procaccio, Francesca Bergamo, Maura Gatti, Benedetta Chiusole, Giuseppina Tierno, Eleonora Bergo, Francesca Daniel, Floriana Nappo, Giulia Maddalena, Cosimo Rasola, Giulia Barsotti, Maria C. De Grandis, Vittoria M. Piva, Mario D. Rizzato, Giuseppe Sergi, Antonella Brunello, Vittorina Zagonel, Sara Lonardi
Approximately 50% of colorectal cancers occur in older patients. International societies recommend geriatric tools to optimise treatment of older patients. Comprehensive Geriatric Assessment (CGA) is a multidimensional assessment used to classify pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7936d76cdb70378dea49e38d524617b7
https://hdl.handle.net/11577/3473566
https://hdl.handle.net/11577/3473566
Autor:
Giovanni Randon, Giulia Maddalena, Marco Maria Germani, Chiara Carlotta Pircher, Paolo Manca, Francesca Bergamo, Mirella Giordano, Caterina Sposetti, Aldo Montagna, Guglielmo Vetere, Luca Zambelli, Cosimo Rasola, Alessandra Boccaccino, Filippo Pagani, Margherita Ambrosini, Marco Massafra, Gabriella Fontanini, Massimo Milione, Matteo Fassan, Chiara Cremolini, Sara Lonardi, Filippo Pietrantonio
PURPOSE Several uncommon genomic alterations beyond RAS and BRAFV600E mutations drive primary resistance to anti–epidermal growth factor receptor (EGFR) monoclonal antibodies in metastatic colorectal cancer (mCRC). Our PRESSING panel (including PIK
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a02d2c2ee0fe60bfccc140b05153c08d
http://hdl.handle.net/11577/3451315
http://hdl.handle.net/11577/3451315
Autor:
Giovanni Randon, Giulia Maddalena, Marco Maria Germani, Filippo Pagani, Francesca Bergamo, Mirella Giordano, Chiara Pircher, Caterina Sposetti, Luca Zambelli, Francesca Corti, Marta Bini, Alessandro Rametta, Andrea Spagnoletti, Aldo Montagna, Matteo Fassan, Alessandra Boccaccino, Guglielmo Vetere, Silvia Damian, Massimo Milione, Filippo de Braud, Chiara Cremolini, Sara Lonardi, Filippo Pietrantonio
Publikováno v:
Cancer Research. 82:1269-1269
Background: Several genomic alterations beyond RAS and BRAFV600E mutations have been preclinically validated as primary resistance drivers to EGFR inhibition in mCRC. We showed that our PRESSING panel (including PIK3CA exon 20/AKT1/PTEN mutations, ER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8134d650b6370202bf5f49fcf4381e4c
https://doi.org/10.1158/1538-7445.am2022-1269
https://doi.org/10.1158/1538-7445.am2022-1269
Autor:
Giulia Maddalena, Alessandra Prete, Federica Buggin, Fable Zustovich, Jessica Cadau, Giuseppe Azzarello, Letizia Procaccio, Caterina Soldà, Mario Domenico Rizzato, Cosimo Rasola, Claudia Galante, Eleonora Bergo, Silvia Montelatici, Ciro Longobardi, Giorgia Boscolo, Filomena Graziani, Luca Boni, Sara Lonardi, Vittorina Zagonel, Francesca Bergamo
Publikováno v:
Journal of Clinical Oncology. 40:e24015-e24015
e24015 Background: Colorectal cancer (CRC) is the second most frequent malignancy in patients (pts) aged 70. Elderly patients are often excluded by clinical trials; however, improvements in quality of life and comorbidities management led to expan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce5ceabb6c7cad62ae8f88d430b8c13e
https://doi.org/10.1200/jco.2022.40.16_suppl.e24015
https://doi.org/10.1200/jco.2022.40.16_suppl.e24015
Autor:
Matteo, Fassan, Massimo, Milione, Giulia, Maddalena, Chiara, Cremolini, Marta, Schirripa, Filippo, Pietrantonio, Nicoletta, Pella, Emanuela, Dell'Aquila, Elisa, Sperti, Clizia, Zichi, Francesca, Bergamo, Marco, Volante, Alessandra, Boccaccino, Federica, Morano, Francesco, Cortiula, Giovanna, De Maglio, Lorenza, Rimassa, Valeria, Smiroldo, Lorenzo, Calvetti, Giuseppe, Aprile, Lisa, Salvatore, Daniele, Santini, Roberta, Salmaso, Giovanni, Centonze, Paola, Biason, Chiara, Borga, Sara, Lonardi, Vittorina, Zagonel, Angelo P, Dei Tos, Massimo, Di Maio, Fotios, Loupakis
Publikováno v:
European journal of cancer (Oxford, England : 1990). 146
Neuroendocrine differentiation has been extensively associated with worse prognosis and to mechanisms of therapy resistance in several epithelial cancers. A high prevalence of neuroendocrine differentiation was recently described inWe assessed synapt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e51e6e87ff78480a21a5d23356658ab
https://pubmed.ncbi.nlm.nih.gov/33607478
https://pubmed.ncbi.nlm.nih.gov/33607478
Autor:
Alessandra Raimondi, Giulia Maddalena, Filippo Pagani, Michele Prisciandaro, Vincenzo Guarini, Dario Trapani, Salvatore Corallo, Maria Di Bartolomeo, Andrea Spallanzani, Filippo de Braud, Federica Morano, Ilaria Depetris, Francesca Corti, Giovanni Fucà, Fotios Loupakis, Alessandro Bocconi, Giuseppe Curigliano, Carmen Belli, Matteo Fassan, Giovanni Randon, Massimiliano Salati, Sara Lonardi, Filippo Pietrantonio, Antonio Marra
Publikováno v:
Oncologist
Background Few real-world series on the efficacy and safety of anti-programmed cell death protein-1(PD-1)/programmed death ligand-1(PD-L1)–based therapy are available in molecularly unselected patients with poor performance status (PS) and specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e406ce2af0a5284c4ed638ec2b0076
http://hdl.handle.net/11577/3341737
http://hdl.handle.net/11577/3341737